Skip to main content
. 2016 Mar-Apr;7(2):87–92. doi: 10.4103/2229-5178.178081

Table 2.

Comparison of 25(OH)D level at baseline between psoriasis patients and controls

graphic file with name IDOJ-7-87-g002.jpg

HHS Vulnerability Disclosure